Deutsche Bank’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-28,840
| Closed | -$99K | – | 4837 |
|
|
2021
Q1 | $99K | Sell |
28,840
-2,698
| -9% | -$8.39K | ﹤0.01% | 3989 |
|
|
2020
Q4 | $79K | Buy |
31,538
+8,942
| +40% | +$19.5K | ﹤0.01% | 3975 |
|
|
2020
Q3 | $48K | Buy |
22,596
+2,148
| +11% | +$5.1K | ﹤0.01% | 3913 |
|
|
2020
Q2 | $46K | Buy |
20,448
+6,717
| +49% | +$17.3K | ﹤0.01% | 3854 |
|
|
2020
Q1 | $35K | Sell |
13,731
-7,598
| -36% | -$18.7K | ﹤0.01% | 3712 |
|
|
2019
Q4 | $55K | Buy |
21,329
+9,723
| +84% | +$29K | ﹤0.01% | 3929 |
|
|
2019
Q3 | $40K | Sell |
11,606
-22,285
| -66% | -$78.9K | ﹤0.01% | 4053 |
|
|
2019
Q2 | $113K | Sell |
33,891
-53,100
| -61% | -$187K | ﹤0.01% | 4147 |
|
|
2019
Q1 | $236K | Sell |
86,991
-39,822
| -31% | -$130K | ﹤0.01% | 3909 |
|
|
2018
Q4 | $352K | Sell |
126,813
-85,267
| -40% | -$279K | ﹤0.01% | 3548 |
|
|
2018
Q3 | $874K | Sell |
212,080
-154,486
| -42% | -$702K | ﹤0.01% | 3432 |
|
|
2018
Q2 | $1.9M | Sell |
366,566
-37,132
| -9% | -$226K | ﹤0.01% | 2995 |
|
|
2018
Q1 | $2.21M | Buy |
403,698
+215,704
| +115% | +$1.52M | ﹤0.01% | 2802 |
|
|
2017
Q4 | $1.53M | Buy |
187,994
+133,176
| +243% | +$1.27M | ﹤0.01% | 2916 |
|
|
2017
Q3 | $572K | Sell |
54,818
-17,529
| -24% | -$195K | ﹤0.01% | 3352 |
|
|
2017
Q2 | $797K | Buy |
72,347
+61,720
| +581% | +$575K | ﹤0.01% | 3174 |
|
|
2017
Q1 | $87K | Sell |
10,627
-17,191
| -62% | -$121K | ﹤0.01% | 3981 |
|
|
2016
Q4 | $192K | Sell |
27,818
-139,816
| -83% | -$892K | ﹤0.01% | 3703 |
|
|
2016
Q3 | $852K | Sell |
167,634
-94,386
| -36% | -$564K | ﹤0.01% | 2927 |
|
|
2016
Q2 | $1.56M | Buy |
262,020
+162,867
| +164% | +$904K | ﹤0.01% | 2576 |
|
|
2016
Q1 | $450K | Buy |
99,153
+20,061
| +25% | +$89.3K | ﹤0.01% | 3278 |
|
|
2015
Q4 | $355K | Buy |
79,092
+67,428
| +578% | +$285K | ﹤0.01% | 3430 |
|
|
2015
Q3 | $36K | Sell |
11,664
-56,628
| -83% | -$172K | ﹤0.01% | 4578 |
|
|
2015
Q2 | $206K | Buy |
68,292
+9,570
| +16% | +$26.9K | ﹤0.01% | 3876 |
|
|
2015
Q1 | $172K | Buy |
58,722
+32,959
| +128% | +$108K | ﹤0.01% | 3859 |
|
|
2014
Q4 | $114K | Buy |
25,763
+25,431
| +7,660% | +$121K | ﹤0.01% | 4645 |
|
|
2014
Q3 | $1K | Sell |
332
-45,979
| -99% | -$245K | ﹤0.01% | 5788 |
|
|
2014
Q2 | $242K | Buy |
46,311
+38,488
| +492% | +$166K | ﹤0.01% | 4012 |
|
|
2014
Q1 | $32K | Buy |
+7,823
| New | +$26.8K | ﹤0.01% | 4709 |
|
|
2013
Q4 | – | Sell |
-14
| Closed | – | – | 5748 |
|
|
2013
Q3 | $0 | Sell |
14
-24,463
| -100% | -$58K | ﹤0.01% | 5774 |
|
|
2013
Q2 | $50K | Buy |
+24,477
| New | +$54K | ﹤0.01% | 4510 |
|
Other funds holding ENZ
HFA
RAM
EGA
VCA
Deutsche Bank's ENZ Position: Q2 2021 in Review
Deutsche Bank sold out of Enzo Biochem, Inc. (ENZ) in Q2 2021, closing a stake of 28,840 shares — an estimated $99K sold.
Deutsche Bank first reported a position in ENZ in Q2 2013 and held it in 31 quarters. The position peaked at $2.21M in Q1 2018. 72 funds tracked by Wall St. Rank hold ENZ as of Q2 2021.
- Deutsche Bank reported no remaining Enzo Biochem, Inc. position as of Q2 2021 after selling out during the quarter.
- Deutsche Bank sold 28,840 Enzo Biochem, Inc. shares in Q2 2021, an estimated $99K.
- Deutsche Bank first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 31 quarters.
- Deutsche Bank's Enzo Biochem, Inc. position peaked at $2.21M in Q1 2018.
- 72 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2021.
Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.